These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Intramolecular subunit interactions between insulin and insulin-like growth factor 1 alpha beta half-receptors induced by ligand and Mn/MgATP binding. Treadway JL; Frattali AL; Pessin JE Biochemistry; 1992 Dec; 31(47):11801-5. PubMed ID: 1445913 [TBL] [Abstract][Full Text] [Related]
25. Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses. Macháčková K; Mlčochová K; Potalitsyn P; Hanková K; Socha O; Buděšínský M; Muždalo A; Lepšík M; Černeková M; Radosavljević J; Fábry M; Mitrová K; Chrudinová M; Lin J; Yurenko Y; Hobza P; Selicharová I; Žáková L; Jiráček J J Biol Chem; 2019 Nov; 294(46):17371-17382. PubMed ID: 31558604 [TBL] [Abstract][Full Text] [Related]
26. Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia. Federici M; Lauro D; D'Adamo M; Giovannone B; Porzio O; Mellozzi M; Tamburrano G; Sbraccia P; Sesti G Diabetes; 1998 Jan; 47(1):87-92. PubMed ID: 9421379 [TBL] [Abstract][Full Text] [Related]
27. Type I insulin-like growth factor receptors in the BeWo choriocarcinoma cell (b30 clone) during cell differentiation. Cohran V; Fang J; Milio L; Smith CH; Fant M Placenta; 1996; 17(5-6):313-20. PubMed ID: 8829214 [TBL] [Abstract][Full Text] [Related]
28. Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling? Blakesley VA; Scrimgeour A; Esposito D; Le Roith D Cytokine Growth Factor Rev; 1996 Aug; 7(2):153-9. PubMed ID: 8899293 [TBL] [Abstract][Full Text] [Related]
29. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Reeve JG; Morgan J; Schwander J; Bleehen NM Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401 [TBL] [Abstract][Full Text] [Related]
30. Characterization of ligand binding of a soluble human insulin-like growth factor I receptor variant suggests a ligand-induced conformational change. Jansson M; Hallén D; Koho H; Andersson G; Berghard L; Heidrich J; Nyberg E; Uhlén M; Kördel J; Nilsson B J Biol Chem; 1997 Mar; 272(13):8189-97. PubMed ID: 9079636 [TBL] [Abstract][Full Text] [Related]
31. Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity. Zhang W; Gustafson TA; Rutter WJ; Johnson JD J Biol Chem; 1994 Apr; 269(14):10609-13. PubMed ID: 8144650 [TBL] [Abstract][Full Text] [Related]
32. Chimeric receptors indicate that phenylalanine 39 is a major contributor to insulin specificity of the insulin receptor. Kjeldsen T; Wiberg FC; Andersen AS J Biol Chem; 1994 Dec; 269(52):32942-6. PubMed ID: 7806523 [TBL] [Abstract][Full Text] [Related]
33. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor. Jansson M; Uhlen M; Nilsson B Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004 [TBL] [Abstract][Full Text] [Related]
34. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor. Zhang B; Roth RA Biochemistry; 1991 May; 30(21):5113-7. PubMed ID: 1645190 [TBL] [Abstract][Full Text] [Related]
35. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system. Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184 [TBL] [Abstract][Full Text] [Related]
37. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657 [TBL] [Abstract][Full Text] [Related]
38. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system. Tartare-Deckert S; Sawka-Verhelle D; Murdaca J; Van Obberghen E J Biol Chem; 1995 Oct; 270(40):23456-60. PubMed ID: 7559507 [TBL] [Abstract][Full Text] [Related]
39. Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media. De Vroede MA; Tseng LY; Katsoyannis PG; Nissley SP; Rechler MM J Clin Invest; 1986 Feb; 77(2):602-13. PubMed ID: 2418066 [TBL] [Abstract][Full Text] [Related]
40. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Soos MA; Field CE; Siddle K Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):419-26. PubMed ID: 8452530 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]